Home > Drug Search >
  • company_query: Angelini Group
  •   > 
Drug Filter
Category:
chemistry (19) biology (3)
Status:
Approved (1) Phase Ⅲ (6) Phase Ⅱ (11) Phase Ⅰ (4)
Clinical Stage:
Pending (4) Active (5) Discontinued (12)
Bio-Type:
Vaccine (1) Recombinant hormone (1)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (1) Asthma (2) Atopic dermatitis (1) Castration-resistant prostate cancer (CRPC) (1) Chronic lymphocytic leukemia (CLL) (1) Crohn's disease (2) Diabetic nephropathy (2) Epilepsy/Seizures (1) Eye disorders (1) HIV infection (1) Hypercholesterolemia (1) Malignancies (1) Melanoma (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Myocardial infarction (MI) (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Pancreatic cancer (1) Partial seizures (1) Prostate cancer (1) Renal cell carcinoma (1) Rheumatoid arthritis (RA) (1) Ulcerative colitis (2) Colorectal cancer (2) Stroke (1) Diabetes (1) Autoimmune diseases (1) Hypotension (1) Ischemic stroke (1) Acute pancreatitis (1) Plaque psoriasis (1) Lupus nephritis (2) Fractures (1) Diffuse large B cell lymphoma (1) Renal failure (1) Coronary restenosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top